In this study, we observed that c-MYC expression (plasma) level in hematological malignancies was significantly higher (8.8 ± 1.1; Mean ± SE) (p<0.05) than that of the apparently healthy control subjects (4.5 ± 0.5; Mean ± SE) (Figure 2). This evidence concerns the gene MYC and hematologic disorder.